Pilocarpine induces the residual secretion of salivary fluid in perfused submandibular glands of rats
暂无分享,去创建一个
[1] S. Porter,et al. Interventions for dry mouth and hyposalivation in Sjögren's syndrome: A systematic review and meta-analysis. , 2018, Oral diseases.
[2] G. Carpenter,et al. Salivary secretion in health and disease , 2018, Journal of oral rehabilitation.
[3] S. Porter,et al. Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis. , 2017, Oral oncology.
[4] Rui-nan Wang,et al. Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. , 2016, Journal of the American Dental Association.
[5] M. Tanasiewicz,et al. Xerostomia of Various Etiologies: A Review of the Literature. , 2016, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[6] T. Nagai,et al. Partial agonistic effects of pilocarpine on Ca2+ responses and salivary secretion in the submandibular glands of live animals , 2015, Experimental physiology.
[7] M. Murakami,et al. Mechanism involved in Danshen-induced fluid secretion in salivary glands. , 2015, World journal of gastroenterology.
[8] G. Carpenter,et al. Salivary secretion: mechanism and neural regulation. , 2014, Monographs in oral science.
[9] G. H. Zhang,et al. Tight junctions and paracellular fluid and ion transport in salivary glands. , 2013, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.
[10] C. Masaki,et al. Cevimeline-Induced Monophasic Salivation from the Mouse Submandibular Gland: Decreased Na+ Content in Saliva Results from Specific and Early Activation of Na+/H+ Exchange , 2011, Journal of Pharmacology and Experimental Therapeutics.
[11] Bing Qi,et al. Characteristics of neurokinin A-induced salivary fluid secretion in perfused rat submandibular gland. , 2010, Archives of oral biology.
[12] M. Dowling,et al. Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 Receptor , 2009, Molecular Pharmacology.
[13] Maria Margaix-Muñoz,et al. Sjögren's syndrome of the oral cavity. Review and update. , 2009, Medicina oral, patologia oral y cirugia bucal.
[14] J. Menani,et al. Central muscarinic receptor subtypes involved in pilocarpine‐induced salivation, hypertension and water intake , 2008, British journal of pharmacology.
[15] S. Oh,et al. Effects of pilocarpine on the secretory acinar cells in human submandibular glands. , 2006, Life sciences.
[16] J. Epstein,et al. Assessment of the use of sialogogues in the clinical management of patients with xerostomia. , 2006, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[17] J. Menani,et al. Damage of the medial preoptic area impairs peripheral pilocarpine-induced salivary secretion , 2006, Brain Research.
[18] T. Begenisich,et al. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. , 2005, Annual review of physiology.
[19] M. N. Ghabriel,et al. Tissue‐specific expression of the tight junction proteins claudins and occludin in the rat salivary glands , 2004, Journal of anatomy.
[20] F. Vivino,et al. A primary care approach to Sjögren's syndrome , 2004, Postgraduate medicine.
[21] J. Wess,et al. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. , 2004, Molecular pharmacology.
[22] J. Menani,et al. Central Muscarinic Receptors Signal Pilocarpine-induced Salivation , 2003, Journal of dental research.
[23] J. Menani,et al. Lesions of the lateral hypothalamus impair pilocarpine-induced salivation in rats , 2002, Brain Research Bulletin.
[24] H. Sugiya,et al. Understanding salivary fluid and protein secretion. , 2002, Oral diseases.
[25] Y. Konttinen,et al. Use of muscarinic agonists in the treatment of Sjögren's syndrome. , 2001, Clinical immunology.
[26] M. Steward,et al. The paracellular component of water flow in the rat submandibular salivary gland , 2001, The Journal of physiology.
[27] F. Vivino. The treatment of Sjögren's syndrome patients with Pilocarpine-tablets , 2001, Scandinavian journal of rheumatology. Supplement.
[28] A. Rubinow,et al. The use of oral pilocarpine in xerostomia and Sjögren's syndrome. , 1999, Seminars in arthritis and rheumatism.
[29] K. Takata,et al. Aquaporin-5 (AQP5), a water channel protein, in the rat salivary and lacrimal glands: immunolocalization and effect of secretory stimulation , 1999, Cell and Tissue Research.
[30] F. Vivino,et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. , 1999, Archives of internal medicine.
[31] F. Ehlert. The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor. , 1996, Life sciences.
[32] F. Ehlert,et al. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] A. K. Willard,et al. A Pharmacokinetic and Pharmacodynamic Study of Intravenous Pilocarpine in Humans , 1995, Journal of dental research.
[34] J. Menani,et al. Involvement of the Central Nervous System in the Salivary Secretion Induced by Pilocarpine in Rats , 1993, Journal of dental research.
[35] J. Johnson,et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. , 1993, The New England journal of medicine.
[36] H. Joensuu,et al. Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. , 1993, Radiotherapy and Oncology.
[37] P. Fox,et al. Effects of pilocarpine on salivary flow in patients with Sjogren's syndrome. , 1992, Oral surgery, oral medicine, and oral pathology.
[38] N. Rhodus,et al. Effects of pilocarpine on salivary flow in patients with Sjögren's syndrome. , 1991, Oral surgery, oral medicine, and oral pathology.
[39] W. Jackson,et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). , 1991, Archives of internal medicine.
[40] Y. Imai,et al. Oxygen consumption for K+ uptake during post‐stimulatory activation of Na+, K(+)‐ATPase in perfused rat mandibular gland. , 1990, The Journal of physiology.
[41] I. Novak,et al. Choline evokes fluid secretion by perfused rat mandibular gland without desensitization. , 1986, The American journal of physiology.
[42] B. Sonies,et al. Xerostomia: evaluation of a symptom with increasing significance. , 1985, Journal of the American Dental Association.
[43] D. Pon,et al. Cholinergic stimulation of ouabain-sensitive respiration in rat submandibular gland. , 1983, The American journal of physiology.
[44] E. Cadman,et al. Sjögren's Syndrome , 1953, Medicine illustrated.